Post Hysterectomy Benefits of Retained Cystoscopy Fluid
| Status: | Recruiting |
|---|---|
| Conditions: | Overactive Bladder, Urology |
| Therapuetic Areas: | Gastroenterology, Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/17/2019 |
| Start Date: | October 10, 2018 |
| End Date: | May 30, 2019 |
| Contact: | Regina Montero, MSN |
| Email: | rmontero52@email.arizona.edu |
| Phone: | 480-239-8697 |
Benefits of Retained Cystoscopy Fluid Following Benign Laparoscopic and Robotic Hysterectomy; A Randomized Controlled Trial
The purpose of this research study is to compare outcomes for women in two study arms that
include retaining the cystoscopy distending fluid after minimally invasive hysterectomy
verses completely emptying the cystoscopy distending fluid. The outcomes being measured for
research purposes include the time spent to first spontaneous urination after surgery, rate
of indwelling catheter insertion, length of recovery room stay, the amount of bladder
discomfort immediately postoperative and over the first 24 hours postoperative, bladder
symptoms over the first 24 hours postoperative, and patient satisfaction.
include retaining the cystoscopy distending fluid after minimally invasive hysterectomy
verses completely emptying the cystoscopy distending fluid. The outcomes being measured for
research purposes include the time spent to first spontaneous urination after surgery, rate
of indwelling catheter insertion, length of recovery room stay, the amount of bladder
discomfort immediately postoperative and over the first 24 hours postoperative, bladder
symptoms over the first 24 hours postoperative, and patient satisfaction.
Acute urinary retention can be a common postoperative complication following hysterectomy.
One of the many benefits of minimally invasive surgery is shorter hospital stay following a
major procedure such as laparoscopic or robotic hysterectomy. An important postoperative
milestone before discharge from the postoperative anesthesia care unit (PACU) is spontaneous
voiding. If unable to spontaneously void due to urinary retention, insertion of an indwelling
catheter may be required. Awaiting a spontaneous void in the recovery room can lead to longer
hospital and PACU stays, greater cost, and patient dissatisfaction. At the conclusion of
traditional laparoscopic or robotic-assisted hysterectomy, intraoperative cystoscopy is
performed to evaluate for urologic injury. One possible strategy to more quickly facilitate a
postoperative spontaneous void is to retain the cystoscopy distending fluid at conclusion of
cystoscopy rather than emptying the bladder of the distending fluid. Although there is no
published research investigating voiding time following laparoscopic or robotic hysterectomy
using strategies such as backfilling the bladder before removal of the indwelling catheter or
retaining the cystoscopy distending fluid following diagnostic cystoscopy.
One of the many benefits of minimally invasive surgery is shorter hospital stay following a
major procedure such as laparoscopic or robotic hysterectomy. An important postoperative
milestone before discharge from the postoperative anesthesia care unit (PACU) is spontaneous
voiding. If unable to spontaneously void due to urinary retention, insertion of an indwelling
catheter may be required. Awaiting a spontaneous void in the recovery room can lead to longer
hospital and PACU stays, greater cost, and patient dissatisfaction. At the conclusion of
traditional laparoscopic or robotic-assisted hysterectomy, intraoperative cystoscopy is
performed to evaluate for urologic injury. One possible strategy to more quickly facilitate a
postoperative spontaneous void is to retain the cystoscopy distending fluid at conclusion of
cystoscopy rather than emptying the bladder of the distending fluid. Although there is no
published research investigating voiding time following laparoscopic or robotic hysterectomy
using strategies such as backfilling the bladder before removal of the indwelling catheter or
retaining the cystoscopy distending fluid following diagnostic cystoscopy.
Inclusion Criteria:
- Female patients, greater than or equal to 18 years old
- English-speaking
- Undergoing laparoscopic or robotic hysterectomy for benign indications by one of the
three minimally invasive gynecologic surgeons at Banner University Medical Center -
Phoenix.
Exclusion Criteria:
- Preoperative indications of pelvic organ prolapse
- Preoperative indications of urinary incontinence
- Lower urologic (bladder or ureteric) injury identified at time of hysterectomy or
during intraoperative cystoscopy
- Patients given any measure to aid in visualization of ureteral patency including
dextrose, phenazopyridine, indigo carmine, methylene blue, sodium fluorescein, or
furosemide.
We found this trial at
1
site
Click here to add this to my saved trials
